Clinical Trials Logo
  1. Home
  2. Bacterial Meningitis
  3. NCT01410474

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan

Bacterial Meningitis Clinical Trial

Official title:
A Phase 3, Multicenter, Open-label Study to Evaluate Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) in Healthy Subjects From 2 to 18 Years in Taiwan

Clinical Trial Summary

This study will evaluate the immunogenicity and safety of a single injection of Novartis Meningococcal ACWY conjugate vaccine in healthy subjects from 2 to 18 years in Taiwan.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01410474
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 3
Start date August 2011
Completion date January 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT01589289 - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC Phase 3
Completed NCT02274285 - DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants Phase 3
Recruiting NCT04771884 - Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Not yet recruiting NCT02467309 - Vitamin d Levels in Children With Bacterial Meningitis N/A
Completed NCT01547715 - Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India Phase 3
Terminated NCT00774631 - IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis Phase 4
Completed NCT00619203 - Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis Phase 3
Recruiting NCT05146570 - Early Diagnosis of Native and Device-associated Meningitis N/A
Completed NCT03595761 - Meningitis With Cerebral Vasculitis in Children
Recruiting NCT03418441 - Central Nervous System Infections in Denmark
Completed NCT01540838 - Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis Phase 4
Recruiting NCT03499652 - Neonatal Bacterial Meningitis Cohort
Completed NCT03226379 - Driving Reduced AIDS-associated Meningo-encephalitis Mortality N/A
Completed NCT03891758 - Confirmatory Study of BK1310 in Healthy Infants Phase 3